Anders L. Carlson, MD
Researcher and Medical Director, International Diabetes Center, Physician Endocrinology, Endocrinology HealthPartners
About

Affiliations/other offices held: Medical director, International Diabetes Center, and director, HealthPartners diabetes program; assistant professor, University of Minnesota Medical School.

Joined the Institute: 2015

Education and training: MD, University of Minnesota Medical School; fellowship in endocrinology, diabetes and metabolism, University of Vermont; residency in internal medicine, Hennepin County Medical Center, Minneapolis.

Overview/research interests: Dr. Carlson’s research interests include diabetes technology, diabetes care delivery and hyperglycemia in oncology patients. Dr. Carlson has participated in several clinical trials through International Diabetes Center focusing on diabetes technology and new therapeutics. He also has experience using molecular techniques in beta cell research.

Publications

CV

Affiliation
positions
  • Sr. Research Investigator, Diabetes
  • Medical Director, International Diabetes Center, International Diabetes Center 2015 -
  • Publications
    selected publications
    Journal Article
  • Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes
    Diabetes Technology & Therapeutics. 2022
  • How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: findings from the first investigation with the Omnipod® 5 System
    Diabetes Research and Clinical Practice. 2022
  • Primary care and diabetes technologies and treatments
    Diabetes Technology & Therapeutics. 2022
  • Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations
    Diabetes Technology & Therapeutics. 2022
  • Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes
    Diabetes Technology & Therapeutics. 2022
  • Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): findings from the T1D exchange
    Journal of Diabetes and Its Complications. 2022
  • A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial
    Lancet (London, England). 2021
  • Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial
    JAMA. 2021
  • Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM Study
    Journal of Diabetes Science and Technology. 2021
  • Improved glycemic control in 3,592 adults with type 2 diabetes mellitus initiating a tubeless insulin management system
    Diabetes Research and Clinical Practice. 2021
  • Initiating insulin in the emergency center and urgent care to prevent hospital admission for patients with hyperglycemia: a unique insulin starter kit
    Journal of Diabetes Science and Technology. 2021
  • Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion
    Diabetes Technology & Therapeutics. 2021
  • Making sense of glucose metrics in diabetes: linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C)
    Postgraduate Medicine. 2021
  • Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes
    Diabetes care. 2021
  • Primary care and diabetes technologies and treatments
    Diabetes Technology & Therapeutics. 2021
  • Renal complications and duration of diabetes: an international comparison in persons with type 1 diabetes
    Diabetes Therapy. 2021
  • The effect of discontinuing continuous glucose monitoring in adults with type 2 diabetes treated with basal insulin
    Diabetes care. 2021
  • Trial of a new diabetes education model: closing the gap in health disparity for people with diabetes
    Journal of Diabetes Science and Technology. 2021
  • Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system
    Diabetes Technology & Therapeutics. 2021
  • Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial
    JAMA. 2020
  • International Diabetes Center: COVID-19 won't stop us from fulfilling our mission
    Journal of Diabetes Science and Technology. 2020
  • Evaluation of insulin glargine and exenatide alone and in combination: a randomized clinical trial with continuous glucose monitoring and ambulatory glucose profile analysis
    Endocrine Practice. 2019
  • Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy
    Journal of Diabetes and Its Complications. 2019
  • The relationships between time in range, hyperglycemia metrics, and HbA1c
    Journal of Diabetes Science and Technology. 2019
  • Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: efficacy and safety from a randomized double-blind trial
    Diabetes, Obesity & Metabolism. 2018
  • The hybrid closed loop therapy system: a step closer to an artificial pancreas
    Minn Physician. 2017
  • Bilateral adrenal incidentalomas: a case report and review of diagnostic challenges
    Case reports in endocrinology. 2013
  • Audio Document
    Contact
    full name
  • Anders L. Carlson, MD
  • Quick Info
     
    Collaboration
    More Info